Want to see SG:42T full AI Analyst Report?
Trendlines Group (42T) Share Price & Analysis
42T Stock Chart & Stats
- Day’s Range
- SGD 0.05 - SGD 0.05
- 52-Week Range
- SGD 0.04 - SGD 0.08
- Previous Close
- SGD 0.05
- Volume
- 150.10K
- Average Volume (3M)
- 363.03K
- Market Cap
- SGD 77.02M
- Enterprise Value
- SGD 80.92M
- Total Cash (Recent Filing)
- SGD 5.01M
- Total Debt (Recent Filing)
- SGD 5.32M
- Price to Earnings (P/E)
- 6.6
- Beta
- 0.45
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet
Low leverage and a sizable equity base reduce financial risk and provide flexibility for Trendlines to support portfolio companies or absorb periods of uneven investment outcomes. This conservative financing profile is a durable strength because it limits debt-related pressure on capital allocation.
Return To Reported Profitability
The return to positive TTM net income, together with strong reported revenue growth, indicates materially improved recent financial performance versus the large losses recorded in 2022–2024. If maintained, this rebound can strengthen reinvestment capacity and portfolio development.
Hands-on Venture-building Model
Trendlines combines investment with management expertise, strategic guidance, and industry networks, giving portfolio companies active commercialization support rather than only supplying capital. This model can build long-term value by helping innovations progress from development toward market adoption.
Bears Say
Weak Cash Generation
Negative operating and free cash flow despite reported net income signals weak earnings conversion and may require reliance on non-cash items or working-capital movements. Persistent cash deficits can constrain Trendlines’ ability to fund portfolio development and reduce financial resilience.
Volatile Earnings Quality
Large swings in profitability and inconsistent margins make it difficult to establish a dependable underlying earnings base for an investment and venture-building company. This reduces confidence that the latest profit rebound will persist without further valuation changes or portfolio-related gains.
Modest Returns On Equity
The substantial equity base has generated only modest TTM returns after several years of negative ROE, indicating that capital has not consistently translated into profitable performance. Persistently low capital productivity could limit compounding and weaken the effectiveness of future investment.
Trendlines Group News
Trendlines Strengthens Portfolio With U.S. Approvals, Expansion and Final Subscription Installment
Trendlines Group ( ($SG:42T) ) has provided an announcement. Trendlines completed the second and final installment of a subscription initiated in June 2025, underscoring continued capital structuring for its investment
EcoPhage Wins EPA Nod for Phage-Based GoldenEco Biopesticide in U.S.
Trendlines Group ( ($SG:42T) ) just unveiled an update. EcoPhage has secured U.S. Environmental Protection Agency approval for GoldenEco, a phage-based biopesticide targeting destructive bacterial diseases in tomatoes and peppers
Trendlines Portfolio Scores U.S. Deals, Patents and EU Project as Fundraising Accelerates
The latest announcement is out from Trendlines Group ( ($SG:42T) ). Trendlines reported a series of portfolio milestones, including ElastiMed securing an exclusive U.S. distribution deal with Nasdaq-listed Tactile Systems
Trendlines’ ElastiMed Secures Exclusive U.S. Distribution Deal for Wearable Compression Device
Trendlines Group ( ($SG:42T) ) has provided an update. Trendlines’ portfolio company ElastiMed has signed an exclusive U.S. distribution agreement with Nasdaq-listed Tactile Medical for MyoSleeve, its discreet, wearable compression
Trendlines Portfolio Firm NICE Surgical Wins U.S. Patent for Colorectal Stapling Device
Trendlines Group ( ($SG:42T) ) just unveiled an announcement. The Trendlines Group’s Singapore-based portfolio company NICE Surgical Solutions has secured a U.S. patent for its purse-string stapler, a device designed
Trendlines taps related-party co-investment to bolster ProArc funding
Trendlines Group ( ($SG:42T) ) just unveiled an announcement. Trendlines Group has approved a co-investment alongside related companies of controlling shareholder Librae Holdings in its portfolio company ProArc. The funding,
42T FAQ
What was Trendlines Group’s price range in the past 12 months?
What is Trendlines Group’s market cap?
When is Trendlines Group’s upcoming earnings report date?
How were Trendlines Group’s earnings last quarter?
Is Trendlines Group overvalued?
Does Trendlines Group pay dividends?
What is Trendlines Group’s EPS estimate?
How many shares outstanding does Trendlines Group have?
What happened to Trendlines Group’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Trendlines Group?
What is the TipRanks Smart Score and how is it calculated?
Trendlines Group Stock Smart Score
Company Description
Trendlines Group
The Trendlines Group Ltd. is a private equity and venture capital firm focused on commercializing innovative technologies. They specialize in early-stage investments, ranging from incubation and seed funding to start-up and even later-stage venture capital for more established companies. Their investment strategy targets high-growth sectors such as food, medical technology (medtech), clean technology, agrifood, agritechnology, and life sciences, specifically emphasizing medical devices, biotechnology, and pharmaceuticals. They also consider opportunities in security, general medical fields, and information technology. The firm primarily seeks to invest in companies located in Israel and Singapore. Beyond financial backing, Trendlines offers extensive support to entrepreneurs, encompassing business incubation, market strategy development, research and development guidance, commercialization services, business development, funding strategies, administrative assistance, and marketing communications. The preferred exit routes for their investments include mergers and acquisitions, public stock listings, or other strategic dispositions of holdings. To mitigate the risks inherent in developing new businesses, Trendlines leverages its own capital alongside government funding. The firm actively participates in all aspects of its portfolio companies, from technological innovation to comprehensive business construction. Founded in 1993, The Trendlines Group Ltd. is headquartered in M.P. Misgav, Israel, and maintains additional offices in Tel Aviv, Israel; Beijing, China; and Singapore.
- Sector
- Financial
- Industry
- Asset Management
- CEO
- Haim Brosh
- Employees
- 20
- Website
- www.trendlines.com
- Address
- Misgav Business Park, M P Misgav, HZ, 2017400, IL
Trendlines Group (42T) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 2 | 4 | 14 |
| Technical Analysis | 1 | 3 | 4 |
| Moving Averages | 1 | 1 | 10 |